Company: CERO
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001213900-25-032134
Chunk: 148

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 1
Chunk 148
---
 any good, facility, item or service for which payment may be made under a federal healthcare program,
such as Medicare or Medicaid. The term “remuneration” has been broadly interpreted to include anything of value;

●Federal false claims, and false statement laws, including the federal civil False Claims Act, and Civil
Monetary Penalties Law, prohibits, among other things, any person or entity from knowingly presenting, or causing to be presented, for
payment to, or approval by, federal programs, including Medicare and Medicaid, claims for items or services, including drugs and biologics,
that are false or fraudulent;

●Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) created additional federal
criminal statutes that prohibit among other actions, knowingly and willfully executing, or attempting to execute, a scheme to defraud
any healthcare benefit program, including private third-party payors or making any false, fictitious or fraudulent statement in connection
with the delivery of or payment for healthcare benefits, items or services;

●HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009 and
their implementing regulations, imposes obligations on certain covered healthcare providers, health plans, and healthcare clearinghouses
and their respective business associates and covered subcontractors types of individuals and entities regarding the electronic exchange
of information in common healthcare transactions, as well as standards relating to the privacy and security of individually identifiable
health information;

●The federal Physician Payments Sunshine Act requires certain manufacturers of drugs, devices, biologics
and medical supplies for which payment is available under Medicare, Medicaid or the Children’s Health Insurance Program, with specific
exceptions, to report annually to the Centers for Medicare and Medicaid Services (“CMS”), information related to payments
or other transfers of value made to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors), physician
assistants, nurse practitioners, clinical nurse specialists, anesthesiologist assistants, certified nurse anesthetists and certified nurse-midwives
and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members.;

●Federal and state laws that require pharmaceutical manufacturers to report product pricing information;
and

●The Foreign Corrupt Practices Act prohibits U.S. businesses and their
representatives from offering to pay, paying, promising to pay or authorizing the payment of money or anything of value to a foreign official
in order to influence any act or decision of the foreign official in his